C12Y 301/01089
Protein phosphatase methylesterase-1
Official title: Protein phosphatase methylesterase-1 (3.1.1.89)
C12Y301/01089 (Protein phosphatase methylesterase-1) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 4
- Assignees
- 1
- Inventors
- 6
- Latest grant
- 1 Jan 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 2 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
By publication year.
Recent patents
- PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition1 Jan 2019US 10,167,472 B2Medical Diagnostic Laboratories, LLC
- PME-1 as a biomarker to predict and diagnose endometrial and breast cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition30 May 2017US 9,663,789 B2Medical Diagnostic Laboratories, LLC
- PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition23 May 2017US 9,657,349 B2Medical Diagnostic Laboratories, LLC
- Pme-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of pme-1 to inhibit epithelial to mesenchymal transition18 Jun 2020US 2020/0190592 A1Medical Diagnostic Laboratories, LLC
- Pme-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of pme-1 to inhibit epithelial to mesenchymal transition10 Aug 2017US 2017/0226520 A1Medical Diagnostic Laboratories, LLC
- Pme-1 as a biomarker to predict and diagnose endometrial and breast cancer and gene silencing of pme-1 to inhibit epithelial to mesenchymal transition8 Oct 2015US 2015/0284723 A1Medical Diagnostic Laboratories, LLC
- Pme-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of pme-1 to inhibit epithelial to mesenchymal transition30 Oct 2014US 2014/0323546 A1Medical Diagnostic Laboratories, LLC
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.